MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED

Andere talen Medical Developments International Limited

Aandelen

MVP

AU000000MVP2

Farmaceutische producten

Beurs gesloten - Australian S.E. Andere beurzen 06:10:28 06-02-2026			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,4500 ^AUD	-2,17%		-4,26%	-18,92%

07/01	Vaxxas benoemt voormalig Merck-wereldwijd vaccins president David Peacock tot CEO	RE
10-10-25	Medical Developments rapporteert omzetstijging van AU$1,9 miljoen in septemberkwartaal	MT

Andere talen

07/01	Vaxxas appoints former Merck global vaccines president David Peacock as CEO
10-10-25	Medical Developments Says Group Revenue for September Quarter Up AU$1.9 Million Year-over-Year
10-10-25	Medical Developments International posts group revenue for Q1 FY26 at A$10.9 mln
22-09-25	Medical Developments International Limited Announces Board Changes
22-08-25	Bell Potter rates MVP as Speculative Buy
21-08-25	Medical Developments International Limited Reports Earnings Results for the Full Year Ended June 30, 2025
21-08-25	Medical Developments International : PAEDIATRIC INDICATION FOR PENTHROX APPROVED BY HPRA
21-08-25	Medical Developments International posts FY revenue AUD 39.1 million
31-07-25	Medical Developments International Group posts revenue for Q4 A$10.2 million
30-05-25	Medical Developments International Limited Announces Board Changes, Effective from 30 May 2025
29-04-25	Medical Developments International (ASX:MVP) to support acute pain management in France through new partnership agreement with Ethypharm
29-04-25	Medical Developments International Says Group Revenue For Q3 FY25 Was A$8.9 Million
21-03-25	Medical Developments International Limited Appoints Mark Fladrich to the Board, Effective April 1, 2025
19-02-25	Medical Developments International Limited Reports Earnings Results for the Half Year Ended December 31, 2024
13-11-24	Medical Developments International Limited Announces Resignation of Mary Sontrop from the Board, Effective December 20, 2024
30-10-24	MEDICAL DEVELOPMENTS INTERNATIONAL : EXTENDS AGREEMENT FOR PENTHROX® (METHOXYFLURANE) DISTRIBUTION WITH GALEN IN UK AND IRELAND
26-08-24	Medical Developments International Limited Reports Earnings Results for the Full Year Ended June 30, 2024
26-07-24	Medical Developments International to Raise AU$10 Million via Placement, Entitlement Offer
12-07-24	Medical Developments International Expects Fiscal 2024 Write-Downs of AU$31 Million
12-07-24	Medical Developments International Limited Provides Group Write-Downs Guidance for the Year 2024
28-02-24	Medical Developments International Limited Reports Earnings Results for the Half Year Ended December 31, 2023
18-09-23	Medical Developments International Limited(ASX:MVP) dropped from S&P/ASX Emerging Companies Index
31-08-23	Medical Developments International Limited Appoints Russell Basser to the Board Effective 1 September 2023
31-08-23	Medical Developments International Limited Reports Earnings Results for the Full Year Ended June 30, 2023
18-04-23	Medical Developments International Limited Announces Resignation of David Williams from Board

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripten Persberichten Officiële publicaties Andere talen MarketScreener-artikels MarketScreener-analyses Ideeën voor de handel

Andere talen Medical Developments International Limited

Aandelen

MVP

AU000000MVP2

Farmaceutische producten

Andere talen

Filters